Results
Vivanza Biosciences FY26 Net Loss ₹96.54 Lakhs Standalone
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a standalone net loss of ₹96.54 lakhs for the year.
Noted resignations of Non-Executi
